$296 Million is the total value of Nextech Invest Ltd.'s 14 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | $76,781,000 | -23.6% | 3,939,529 | 0.0% | 25.90% | -9.7% | |
| EQRX INC | $61,460,000 | +13.6% | 13,104,424 | 0.0% | 20.73% | +34.2% | ||
| KNTE | KINNATE BIOPHARMA INC | $37,934,000 | +12.0% | 3,008,243 | 0.0% | 12.80% | +32.3% | |
| PMVP | PMV PHARMACEUTICALS INC | $19,748,000 | -31.6% | 1,385,807 | 0.0% | 6.66% | -19.1% | |
| TYRA BIOSCIENCES INC | $18,008,000 | -33.2% | 2,518,582 | 0.0% | 6.07% | -21.1% | ||
| MRTX | Buy | MIRATI THERAPEUTICS INC | $17,717,000 | +24.3% | 263,914 | +52.3% | 5.98% | +46.9% |
| CGEM | CULLINAN ONCOLOGY INC | $15,655,000 | +22.4% | 1,221,145 | 0.0% | 5.28% | +44.7% | |
| ARVN | ARVINAS INC | $12,090,000 | -37.5% | 287,251 | 0.0% | 4.08% | -26.1% | |
| BPMC | BLUEPRINT MEDICINES CORP | $9,507,000 | -20.9% | 188,228 | 0.0% | 3.21% | -6.6% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $8,099,000 | +20.8% | 1,910,029 | 0.0% | 2.73% | +42.7% | |
| RLAY | RELAY THERAPEUTICS INC | $7,964,000 | -44.0% | 475,485 | 0.0% | 2.69% | -33.9% | |
| KRON | KRONOS BIO INC | $5,284,000 | -49.7% | 1,451,537 | 0.0% | 1.78% | -40.5% | |
| THESEUS PHARMACEUTICALS INC | $3,381,000 | -52.0% | 611,310 | 0.0% | 1.14% | -43.3% | ||
| CCCC | C4 THERAPEUTICS INC | $2,834,000 | -68.9% | 375,857 | 0.0% | 0.96% | -63.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
| EQRX INC | 8 | Q3 2023 | 23.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
| KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
| CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
| PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
| ARVINAS INC | 8 | Q3 2023 | 6.2% |
| SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
| THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-01 |
| 13F-HR/A | 2022-05-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.